Latest 25 News in the Life Sciences Industry
GlobeNewswire
ImPact Biotech Presents Updated Data from Phase 3 ENLIGHTED Trial of Padeliporfin VTP in LG-UTUC at AUA 2026
16 May 2026
GlobeNewswire
CJ Biomaterials Launches New Home Compostable all-PHA Extrusion Coating Resin for Paper Food Serviceware
14 May 2026
GlobeNewswire
Chemomab Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update
14 May 2026
GlobeNewswire
NurExone Advances to Stage 2 of EU-Backed EIT Health Catapult Programme 2026
14 May 2026
GlobeNewswire
Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
14 May 2026
GlobeNewswire
PolyPid Provides Corporate Update and Reports First Quarter 2026 Financial Results
13 May 2026
GlobeNewswire
IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization
13 May 2026
PR Newswire Association LLC.
InMode to Present at Upcoming Investor Conferences and Events
13 May 2026
GlobeNewswire
Polyrizon Advances Towards Human Clinical Trials: Secures First U.S. Clinical Site for NASARIX™ Allergy Blocker Clinical Trial
13 May 2026
GlobeNewswire
Kamada Reports First Quarter 2026 Financial Results and Affirms 2026 Annual Guidance; Expecting Significantly Stronger Remainder of the Year
13 May 2026
GlobeNewswire
Following Positive Phase 2a Pancreatic Cancer Data, Can-Fite Advances Namodenoson into Phase 2b Combination Study with Immunotherapy
13 May 2026
PR Newswire Association LLC.
IceCure Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
13 May 2026
GlobeNewswire
BrainsWay Reports First Quarter 2026 Financial Results and Operational Highlights
13 May 2026
GlobeNewswire
Boehringer Ingelheim licenses preclinical antibody program from Immunitas Therapeutics to advance treatments for chronic inflammatory diseases
12 May 2026
GlobeNewswire
Bolt Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
12 May 2026
PR Newswire Association LLC.
Pulse Equity: Emerging Outbreaks - Polyrizon's Approach to Broad and Rapidly Deployable Protection
11 May 2026
PR Newswire Association LLC.
IceCure Medical to Report First Quarter 2026 Financial and Operating Results on May 12, 2026
06 May 2026
PR Newswire Association LLC.
TEN-YEAR PIVOTAL DATA REINFORCE THE LONG-TERM DURABILITY OF EDWARDS' RESILIA TISSUE
04 May 2026
PR Newswire Association LLC.
Everads Announces Publication of First-in-Human Clinical Data for Its Suprachoroidal Injector in Ophthalmology Science and Three Presentations at ARVO 2026
03 May 2026
Upcoming Events All Events
- May 2026
- Copenhagen: LSX Nordic Congress
- Basel: Pharma Partnering EU Summit 2026
- London: UK Biotech Day